Patents by Inventor Jonathon Oliver Whitehouse

Jonathon Oliver Whitehouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
    Patent number: 10258616
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: April 16, 2019
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE
    Publication number: 20180064704
    Abstract: The present invention pertains to oral immediate release pharmaceutical compositions suitable for treating patients suffering from pain comprising oxycodone and naloxone or their pharmaceutically acceptable salts.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 8, 2018
    Inventors: Helen Kathleen DANAGHER, Geoffrey Gerard HAYES, Gerhard Josef HEUN, Hassan MOHAMMAD, Malcolm WALDEN, Jonathon Oliver WHITEHOUSE
  • HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME
    Publication number: 20180064705
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 8, 2018
    Inventors: Helen Kathleen DANAGHER, Hassan MOHAMMAD, Malcolm WALDEN, Geoffrey Gerard HAYES, Jonathon Oliver WHITEHOUSE, Thinnayam Naganathan KRISHNAMURTHY, Ricardo Alberto VARGAS RINCON
  • Immediate release pharmaceutical compositions comprising oxycodone and naloxone
    Patent number: 9820983
    Abstract: The present invention pertains to oral immediate release pharmaceutical compositions suitable for treating patients suffering from pain comprising oxycodone and naloxone or their pharmaceutically acceptable salts.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: November 21, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Helen Kathleen Danagher, Geoffrey Gerard Hayes, Gerhard Josef Heun, Hassan Mohammad, Malcolm Walden, Jonathon Oliver Whitehouse
  • Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
    Patent number: 9814710
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: November 14, 2017
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • Pharmaceutical compositions comprising hydromorphone and naloxone
    Patent number: 9700508
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: July 11, 2017
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME
    Publication number: 20160296516
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 13, 2016
    Inventors: Helen Kathleen DANAGHER, Hassan MOHAMMAD, Malcolm WALDEN, Geoffrey Gerard HAYES, Jonathon Oliver WHITEHOUSE, Thinnayam Naganathan KRISHNAMURTHY, Ricardo Alberto VARGAS RINCON
  • IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE
    Publication number: 20160136156
    Abstract: The present invention pertains to oral immediate release pharmaceutical compositions suitable for treating patients suffering from pain comprising oxycodone and naloxone or their pharmaceutically acceptable salts.
    Type: Application
    Filed: January 21, 2016
    Publication date: May 19, 2016
    Inventors: Helen Kathleen Danagher, Geoffrey Gerard Hayes, Gerhard Josef Heun, Hassan Mohammad, Malcolm Walden, Jonathon Oliver Whitehouse
  • Immediate release pharmaceutical compositions comprising oxycodone and naloxone
    Patent number: 9271940
    Abstract: The present invention pertains to oral immediate release pharmaceutical compositions suitable for treating patients suffering from pain comprising oxycodone and naloxone or their pharmaceutically acceptable salts.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: March 1, 2016
    Assignee: Purdue Pharma L.P.
    Inventors: Helen Kathleen Danagher, Geoffrey Gerard Hayes, Gerhard Josef Heun, Hassan Mohammad, Malcolm Walden, Jonathon Oliver Whitehouse
  • Pharmaceutical spheroids
    Patent number: 9034373
    Abstract: According to the invention glyceryl monostearate and a polymeric binder are employed as a spheronising aid in the manufacture of pharmaceutical spheroids containing no or substantially no microcrystalline cellulose. The spheroids can contain one or more therapeutically active agent which undergoes no or substantially no degradation when stored under accelerated temperature and humidity conditions. A coating may be applied to the spheroids; when present, the coating is preferably a controlled release coating.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: May 19, 2015
    Assignee: EURO-CELTIQUE S.A.
    Inventors: Malcolm Walden, Hassan Mohammad, Geoffrey Gerard Hayes, Helen Kathleen Danagher, Jonathon Oliver Whitehouse
  • PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
    Publication number: 20130178492
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.
    Type: Application
    Filed: May 10, 2011
    Publication date: July 11, 2013
    Applicant: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE
    Publication number: 20120088786
    Abstract: The present invention pertains to oral immediate release pharmaceutical compositions suitable for treating patients suffering from pain comprising oxycodone and naloxone or their pharmaceutically acceptable salts.
    Type: Application
    Filed: March 10, 2010
    Publication date: April 12, 2012
    Inventors: Helen Kathleen Dadagher, Geoffrey Gerard Hayes, Gerhard Josef Heun, Hassan Mohammad, Malcolm Walden, Jonathon Oliver Whitehouse